|
OMIM |
Link |
Information gain |
01 |
|
DYTCA
|
[NCBI]
|
0.00111241
|
|
|
systemic lupus erythematosus, susceptibility to, 5
|
[NCBI]
|
0.00111241
|
|
|
SPG32
|
[NCBI]
|
0.00111241
|
|
|
CMD1Q
|
[NCBI]
|
0.00111241
|
|
|
myopathy, limb-girdle, with bone fragility
|
[NCBI]
|
0.00111241
|
|
|
ETL4
|
[NCBI]
|
0.00111241
|
|
|
RP32
|
[NCBI]
|
0.00111241
|
|
|
EA3
|
[NCBI]
|
0.000847756
|
|
|
polymicrogyria, unilateral
|
[NCBI]
|
0.000847756
|
|
|
CHNG3
|
[NCBI]
|
0.000847756
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.00074821
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00074821
|
|
|
cataract, age-related cortical
|
[NCBI]
|
0.00074821
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.00074821
|
|
|
EA4
|
[NCBI]
|
0.000683762
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000683762
|
|
|
IH
|
[NCBI]
|
0.000566543
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
0.000516261
|
|
|
MAFD6
|
[NCBI]
|
0.000469331
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
0.00046006
|
|
|
MYP2
|
[NCBI]
|
0.000430488
|
|
|
VUR1
|
[NCBI]
|
0.000363476
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.000363476
|
|
|
holoprosencephaly
|
[NCBI]
|
0.00029591
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
0.000235416
|
|
|
deafness, congenital, with inner ear agenesis, microtia, and microdontia
|
[NCBI]
|
0.000144725
|
|
|
PPAB
|
[NCBI]
|
0.000144725
|
|
|
mental retardation, keratoconus, febrile seizures, and sinoatrial block
|
[NCBI]
|
0.000144725
|
|
|
RP31
|
[NCBI]
|
0.000116966
|
|
|
electroencephalographic peculiarity: fronto-precentral beta wave groups
|
[NCBI]
|
0.000116966
|
|
|
PPCD2
|
[NCBI]
|
0.000116966
|
|
|
CMT2K
|
[NCBI]
|
0.000116966
|
|
|
DFNB67
|
[NCBI]
|
0.000106497
|
|
|
FECD1
|
[NCBI]
|
0.000106497
|
|
|
PWS
|
[NCBI]
|
0.000103015
|
|
|
VAMAS1
|
[NCBI]
|
9.97041e-05
|
|
|
BBS
|
[NCBI]
|
8.87016e-05
|
|
|
KCS
|
[NCBI]
|
8.44391e-05
|
|
|
CMT4B1
|
[NCBI]
|
8.44391e-05
|
|
|
IBMPFD
|
[NCBI]
|
8.44391e-05
|
|
|
CMT4B2
|
[NCBI]
|
8.19426e-05
|
|
|
VLDLRCH
|
[NCBI]
|
8.19426e-05
|
|
|
PDP
|
[NCBI]
|
8.19426e-05
|
|
|
CMT4C
|
[NCBI]
|
7.97264e-05
|
|
|
CMT4D
|
[NCBI]
|
7.97264e-05
|
|
|
CMT4A
|
[NCBI]
|
7.59247e-05
|
|
|
USH3
|
[NCBI]
|
7.42677e-05
|
|
|
OPD1
|
[NCBI]
|
7.42677e-05
|
|
|
WS2A
|
[NCBI]
|
7.42677e-05
|
|
|
alexander disease
|
[NCBI]
|
6.99996e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
6.87611e-05
|
|
|
GABEB
|
[NCBI]
|
6.75964e-05
|
|
|
polycythemia vera
|
[NCBI]
|
6.54568e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
6.54568e-05
|
|
|
UCMD
|
[NCBI]
|
6.44691e-05
|
|
|
SCA17
|
[NCBI]
|
6.44691e-05
|
|
|
GLC3A
|
[NCBI]
|
6.44691e-05
|
|
|
RMD
|
[NCBI]
|
6.17758e-05
|
|
|
SMA2
|
[NCBI]
|
6.01681e-05
|
|
|
SPDA1
|
[NCBI]
|
5.86841e-05
|
|
|
homocysteinemia
|
[NCBI]
|
5.73064e-05
|
|
|
SLE
|
[NCBI]
|
5.70695e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
5.48166e-05
|
|
|
campomelic dysplasia
|
[NCBI]
|
5.42418e-05
|
|
|
SMA3
|
[NCBI]
|
5.36838e-05
|
|
|
CMTX1
|
[NCBI]
|
5.36838e-05
|
|
|
OCA1A
|
[NCBI]
|
5.31416e-05
|
|
|
GLC1A
|
[NCBI]
|
5.26146e-05
|
|
|
GTS
|
[NCBI]
|
5.19609e-05
|
|
|
AS
|
[NCBI]
|
5.08353e-05
|
|
|
MTM1
|
[NCBI]
|
4.60904e-05
|
|
|
MLH1
|
[NCBI]
|
4.50491e-05
|
|
|
LQT1
|
[NCBI]
|
4.46772e-05
|
|
|
SMN1
|
[NCBI]
|
4.2823e-05
|
|
|
CMT1A
|
[NCBI]
|
4.18462e-05
|
|
|
ALS1
|
[NCBI]
|
4.12726e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
4.12726e-05
|
|
|
MYOC
|
[NCBI]
|
4.09544e-05
|
|
|
SMA1
|
[NCBI]
|
3.93971e-05
|
|
|
AHO
|
[NCBI]
|
3.93971e-05
|
|
|
LHFPL5
|
[NCBI]
|
3.87304e-05
|
|
|
COL8A2
|
[NCBI]
|
3.67101e-05
|
|
|
FFI
|
[NCBI]
|
3.53222e-05
|
|
|
NLRP1
|
[NCBI]
|
3.52081e-05
|
|
|
OPMD
|
[NCBI]
|
3.415e-05
|
|
|
ADHD
|
[NCBI]
|
3.415e-05
|
|
|
DLG5
|
[NCBI]
|
3.40115e-05
|
|
|
TOPORS
|
[NCBI]
|
3.40115e-05
|
|
|
NIPBL
|
[NCBI]
|
3.21651e-05
|
|
|
KCNMB1
|
[NCBI]
|
3.0165e-05
|
|
|
SCN8A
|
[NCBI]
|
2.96247e-05
|
|
|
TPH2
|
[NCBI]
|
2.86728e-05
|
|
|
RP
|
[NCBI]
|
2.86302e-05
|
|
|
AGXT
|
[NCBI]
|
2.82488e-05
|
|
|
SPAM1
|
[NCBI]
|
2.82488e-05
|
|
|
PRX
|
[NCBI]
|
2.82488e-05
|
|
|
CCKAR
|
[NCBI]
|
2.78532e-05
|
|
|
GDAP1
|
[NCBI]
|
2.78532e-05
|
|
|
SGCE
|
[NCBI]
|
2.64922e-05
|
|
|
FGF3
|
[NCBI]
|
2.64922e-05
|
|
|
DLK1
|
[NCBI]
|
2.56445e-05
|
|
|
CYP1B1
|
[NCBI]
|
2.53871e-05
|
|
|
IRF1
|
[NCBI]
|
2.51404e-05
|
|
|
CDH23
|
[NCBI]
|
2.51404e-05
|
|
|
CAPN3
|
[NCBI]
|
2.34696e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
2.33987e-05
|
|
|
IL12B
|
[NCBI]
|
2.32905e-05
|
|
|
CLCN1
|
[NCBI]
|
2.31168e-05
|
|
|
PPOX
|
[NCBI]
|
2.29481e-05
|
|
|
PRPH2
|
[NCBI]
|
2.26246e-05
|
|
|
MYO7A
|
[NCBI]
|
2.26246e-05
|
|
|
SNRPN
|
[NCBI]
|
2.20268e-05
|
|
|
SMN2
|
[NCBI]
|
2.20268e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.18865e-05
|
|
|
SOX9
|
[NCBI]
|
2.14845e-05
|
|
|
MSTN
|
[NCBI]
|
2.08707e-05
|
|
|
RP2
|
[NCBI]
|
2.07554e-05
|
|
|
RPGR
|
[NCBI]
|
1.99067e-05
|
|
|
KCNQ1
|
[NCBI]
|
1.97126e-05
|
|
|
MFS
|
[NCBI]
|
1.96229e-05
|
|
|
HRAS
|
[NCBI]
|
1.96179e-05
|
|
|
LRRK2
|
[NCBI]
|
1.85106e-05
|
|
|
BWS
|
[NCBI]
|
1.62289e-05
|
|
|
TPMT
|
[NCBI]
|
1.56453e-05
|
|
|
GJB1
|
[NCBI]
|
1.56453e-05
|
|
|
RET
|
[NCBI]
|
1.51519e-05
|
|
|
DDC
|
[NCBI]
|
1.49828e-05
|
|
|
HMBS
|
[NCBI]
|
1.4466e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.3687e-05
|
|
|
PRNP
|
[NCBI]
|
1.24792e-05
|
|
|
KCNH2
|
[NCBI]
|
1.22464e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.20966e-05
|
|
|
FGFR3
|
[NCBI]
|
1.12977e-05
|
|
|
FTD
|
[NCBI]
|
7.97768e-06
|
|
|
HD
|
[NCBI]
|
6.54187e-06
|
|
|
CD
|
[NCBI]
|
6.24621e-06
|
|
|
FA
|
[NCBI]
|
5.9892e-06
|
|
|
GAPDH
|
[NCBI]
|
5.25168e-06
|
|
|
VDR
|
[NCBI]
|
2.97792e-06
|
|
|
PD
|
[NCBI]
|
2.81588e-06
|
|
|
CJD
|
[NCBI]
|
2.29515e-06
|
|
|
VEGF
|
[NCBI]
|
2.04574e-06
|
|
|
APC
|
[NCBI]
|
1.03036e-06
|
|
|
APOE
|
[NCBI]
|
1.00789e-06
|
|
|
CRC
|
[NCBI]
|
8.93369e-07
|
|
|
BDNF
|
[NCBI]
|
5.41371e-07
|
|
|
CCK
|
[NCBI]
|
4.3262e-07
|
|
|
GFAP
|
[NCBI]
|
3.37969e-07
|
|
|
EGFR
|
[NCBI]
|
8.7948e-09
|
|
|
PTH
|
[NCBI]
|
2.17609e-09
|
|